{
    "clinical_study": {
        "@rank": "50151", 
        "arm_group": [
            {
                "arm_group_label": "Levofloxacin-bismuth therapy", 
                "arm_group_type": "Experimental", 
                "description": "14 day levo\ufb02oxacin and bismuth-containing therapy:PPI,bismuth, amoxicillin, levo\ufb02oxacin"
            }, 
            {
                "arm_group_label": "classical quadruple therapy", 
                "arm_group_type": "Active Comparator", 
                "description": "14 day classical quadruple therapy:PPI,bismuth, metronidazole, tetracycline"
            }
        ], 
        "brief_summary": {
            "textblock": "To test the ef\ufb01cacy of 14 day levo\ufb02oxacin and bismuth-containing second-line therapy for\n      resistant Helicobacter pylori infection, to compare with the classical quadruple therapy."
        }, 
        "brief_title": "Levo\ufb02oxacin and Bismuth-containing Therapy Versus Quadruple Therapy as Second-line Treatment of Resistant Helicobacter Pylori Infection", 
        "completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "condition": "Cure Rate of Helicobacter Pylori Infection", 
        "condition_browse": {
            "mesh_term": "Helicobacter Infections"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  all patients had failed H.pylori therapies including clarithromycin, metronidazole\n             and/or amoxicillin (if not allergic) before.\n\n        Exclusion Criteria:\n\n          -  patients less than 18 years old,\n\n          -  previous gastric surgery,\n\n          -  pregnancy,\n\n          -  lactation,\n\n          -  major systemic diseases,\n\n          -  administration of antibiotics,\n\n          -  bismuth,\n\n          -  antisecretory drugs in the preceding 8 weeks, or\n\n          -  allergy to any one of the medication used in the quadruple regimens."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "19 Years"
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "December 2, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01742429", 
            "org_study_id": "rjkls2012008"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Levofloxacin-bismuth therapy", 
                    "classical quadruple therapy"
                ], 
                "intervention_name": "Proton pump inhibitor", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Levofloxacin-bismuth therapy", 
                    "classical quadruple therapy"
                ], 
                "intervention_name": "Bismuth subsalicylate", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "classical quadruple therapy", 
                "description": "antibiotic", 
                "intervention_name": "Metronidazole", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "classical quadruple therapy", 
                "description": "antibiotic", 
                "intervention_name": "Tetracycline", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Levofloxacin-bismuth therapy", 
                "description": "antibiotic", 
                "intervention_name": "Amoxicillin", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Levofloxacin-bismuth therapy", 
                "description": "antibiotic", 
                "intervention_name": "Levofloxacin", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Tetracycline", 
                "Amoxicillin", 
                "Ofloxacin", 
                "Metronidazole", 
                "Bismuth", 
                "Bismuth subsalicylate", 
                "Proton Pump Inhibitors"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Helicobacter pylori", 
            "second line treatment"
        ], 
        "lastchanged_date": "June 1, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Shanghai", 
                    "country": "China", 
                    "state": "Shanghai", 
                    "zip": "200127"
                }, 
                "name": "Renji Hospital, Shanghai Jiao-Tong University School of Medicine"
            }
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "2", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "China: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "urease breath test", 
            "measure": "eradication rate", 
            "safety_issue": "Yes", 
            "time_frame": "2 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01742429"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Shanghai Jiao Tong University School of Medicine", 
            "investigator_full_name": "Dr. HONG LU", 
            "investigator_title": "Prof. of Medicine", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Shanghai Jiao Tong University School of Medicine", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Shanghai Jiao Tong University School of Medicine", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}